Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gotham Enhanced 500 ETF
GSPY
|
+$48.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$30.3M |
| 3 |
Exelon
EXC
|
+$17.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$17.3M |
| 5 |
PayPal
PYPL
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eaton
ETN
|
+$10.3M |
| 2 |
Advanced Micro Devices
AMD
|
+$7.71M |
| 3 |
CERN
Cerner Corp
CERN
|
+$7.37M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$7.26M |
| 5 |
DTE Energy
DTE
|
+$7.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.88% |
| 3 | Industrials | 10.78% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Financials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
1076
Kyntra Bio
KYNB
$30.4M
| $114K | ﹤0.01% |
+430
| New | +$110K |
|
1077
Archrock
AROC
$5.58B
| $107K | ﹤0.01% |
12,974
-19,820
| -60% | -$182K |
|
|
EB
1078
DELISTED
Eventbrite
EB
| $107K | ﹤0.01% |
+10,390
| New | +$124K |
|
|
CCC
1079
CCC Intelligent Solutions
CCC
$4.39B
| $104K | ﹤0.01% |
+11,288
| New | +$104K |
|
|
SLI
1080
Standard Lithium
SLI
$612M
| $104K | ﹤0.01% |
24,485
+5,628
| +30% | +$33.3K |
|
1081
GrafTech
EAF
$178M
| $100K | ﹤0.01% |
1,409
-872
| -38% | -$76K |
|
1082
Peloton Interactive
PTON
$2.37B
| $99K | ﹤0.01% |
+10,810
| New | +$173K |
|
1083
Nu Holdings
NU
$70.4B
| $92K | ﹤0.01% |
+24,626
| New | +$125K |
|
|
NEUE
1084
DELISTED
NeueHealth
NEUE
| $89K | ﹤0.01% |
+613
| New | +$89.2K |
|
|
WW
1085
DELISTED
WW International
WW
| $87K | ﹤0.01% |
13,637
-30,528
| -69% | -$257K |
|
|
IMGN
1086
DELISTED
Immunogen Inc
IMGN
| $86K | ﹤0.01% |
19,026
+3,652
| +24% | +$15.9K |
|
1087
NovaGold Resources
NG
$3.83B
| $84K | ﹤0.01% |
+17,567
| New | +$110K |
|
1088
Hudbay
HBM
$13.4B
| $79K | ﹤0.01% |
19,373
-3,247
| -14% | -$19.4K |
|
|
AMPS
1089
DELISTED
Altus Power
AMPS
| $76K | ﹤0.01% |
+11,970
| New | +$80K |
|
1090
Oaktree Specialty Lending
OCSL
$1.14B
| $73K | ﹤0.01% |
+3,709
| New | +$78.1K |
|
1091
ADT
ADT
$5.39B
| $70K | ﹤0.01% |
+11,323
| New | +$78.9K |
|
1092
Alto Ingredients
ALTO
$340M
| $70K | ﹤0.01% |
+18,936
| New | +$98.9K |
|
1093
EVgo
EVGO
$214M
| $67K | ﹤0.01% |
+11,147
| New | +$106K |
|
|
ACB
1094
Aurora Cannabis
ACB
$249M
| $66K | ﹤0.01% |
4,964
+3,009
| +154% | +$75.3K |
|
1095
Nordic American Tanker
NAT
$1.48B
| $66K | ﹤0.01% |
+30,834
| New | +$73.7K |
|
1096
Organogenesis Holdings
ORGO
$232M
| $58K | ﹤0.01% |
11,865
-22,663
| -66% | -$140K |
|
1097
MannKind Corp
MNKD
$1.33B
| $55K | ﹤0.01% |
+14,526
| New | +$53.4K |
|
1098
BGC Group
BGC
$5.63B
| $53K | ﹤0.01% |
+15,734
| New | +$54.8K |
|
|
NKLA
1099
DELISTED
Nikola Corporation Common Stock
NKLA
| $49K | ﹤0.01% |
+341
| New | +$69.7K |
|
1100
Pitney Bowes
PBI
$2.26B
| $42K | ﹤0.01% |
+11,725
| New | +$53.4K |
|
Similar funds
Joel Greenblatt's Q2 2022 Portfolio in Review
As of Q2 2022, Joel Greenblatt held 1,290 positions worth $3.11B, down 3.6% from $3.23B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Joel Greenblatt deployed $461M of net new capital in Q2 2022, opening 177 new positions and adding to 577 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 42,001 shares worth $15.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Eaton, an estimated $10.3M trimmed.
- Joel Greenblatt's largest Q2 2022 buy was iShares Core S&P 500 ETF: 42,001 shares worth $15.9M.
- Joel Greenblatt added most to Gotham Enhanced 500 ETF in Q2 2022, an estimated $48.7M increase.
- Joel Greenblatt's biggest Q2 2022 reduction was Eaton, cutting an estimated $10.3M.
- Joel Greenblatt fully exited Cerner Corp in Q2 2022, selling an estimated $7.37M.
- Joel Greenblatt's ten largest holdings make up 22% of its $3.11B portfolio in Q2 2022.
- Joel Greenblatt opened 177 new positions and closed 186 in Q2 2022.
- Joel Greenblatt's portfolio value fell 3.6% quarter-over-quarter to $3.11B.
Based on Gotham Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.